UPDATED Jun 25, 2024
Most likely to generate positive returns on buybacks.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVA | CA$13.63 | 0.7% | 33.8% | CA$2.8b | CA$16.33 | PE8.7x | E24.4% | n/a | Energy | ||
RHIM | UK£34.20 | 6.2% | 28.0% | UK£1.6b | UK£41.32 | PE11.6x | E16.6% | 4.4% | Materials | ||
TGLS | US$41.03 | -6.9% | -19.2% | US$2.0b | US$57.83 | PE11.7x | E7.1% | 1.1% | Capital Goods | ||
NVAX | US$14.00 | 1.6% | 97.7% | US$2.0b | US$22.80 | PS2x | E65.6% | n/a | Pharmaceuticals & Biotech | ||
SINCH | SEK 24.00 | 8.8% | -4.5% | SEK 20.2b | SEK 41.44 | PE653.2x | E54.0% | n/a | Software | ||
SEDG | US$26.40 | -28.8% | -89.7% | US$1.9b | US$61.50 | PB0.7x | E73.8% | n/a | Semiconductors | ||
SMTC | US$29.76 | 0.9% | 18.8% | US$1.9b | US$51.80 | PS2.3x | E157.3% | n/a | Semiconductors | ||
SAH | US$53.96 | -5.4% | 12.1% | US$1.9b | US$58.83 | PE10.6x | E14.7% | 2.2% | Retail | ||
APE | AU$10.89 | 3.2% | -17.2% | AU$2.8b | AU$11.96 | PE10x | E-0.8% | 6.8% | Retail | ||
PTGX | US$31.71 | -2.7% | 12.9% | US$1.9b | US$43.83 | PE11.5x | E-1.7% | n/a | Pharmaceuticals & Biotech | ||
KMT | US$23.36 | -1.2% | -17.2% | US$1.9b | US$25.38 | PE16.9x | E8.6% | 3.4% | Capital Goods | ||
SONO | US$14.70 | -0.6% | -6.1% | US$1.9b | US$23.80 | PS1.2x | E84.7% | n/a | Consumer Durables | ||
HR.UN | CA$8.85 | 0.1% | -12.4% | CA$2.5b | CA$11.13 | PB0.4x | E86.4% | 7.9% | Real Estate | ||
VET | CA$15.49 | 0.6% | -3.8% | CA$2.5b | CA$21.10 | PS1.4x | E48.5% | 3.1% | Energy | ||
HBI | US$4.95 | -0.6% | 9.0% | US$1.8b | US$5.66 | PB5.1x | E-3.1% | 0% | Consumer Durables | ||
ARYN | CHF 1.62 | -3.7% | 9.0% | CHF 1.6b | CHF 2.19 | PE24.6x | E18.8% | 0% | Food, Beverage & Tobacco | ||
DRH | US$8.30 | 0.5% | 7.0% | US$1.8b | US$10.15 | PB1.1x | E14.4% | 1.4% | Real Estate | ||
STGW | US$6.60 | 1.9% | -12.4% | US$1.8b | US$8.00 | PB2.2x | E70.7% | n/a | Media | ||
VCYT | US$22.73 | 6.2% | -10.3% | US$1.8b | US$29.83 | PS4.6x | E122.1% | n/a | Pharmaceuticals & Biotech | ||
TWEKA | €40.76 | 2.4% | -8.8% | €1.6b | €53.78 | PE9.8x | E6.6% | 4.2% | Capital Goods | ||
NEU | AU$20.22 | 1.4% | 65.1% | AU$2.6b | AU$28.56 | PE16.5x | E1.4% | n/a | Pharmaceuticals & Biotech | ||
COMP | US$3.54 | -1.4% | 3.8% | US$1.7b | US$4.23 | PB5.3x | E81.0% | n/a | Real Estate Management and Development | ||
UPBD | US$30.94 | -1.9% | -1.0% | US$1.7b | US$42.29 | PB2.9x | E37.3% | 4.8% | Retail | ||
IPCO | CA$18.66 | 3.8% | 79.1% | CA$2.3b | CA$19.39 | PE10.1x | E-5.9% | n/a | Energy |